Tumor Necrosis Factor-Alpha Antagonist Interferes With the Formation of Granulomatous Multinucleated Giant Cells: New Insights Into
Adalimumab
/ pharmacology
Anti-Inflammatory Agents
/ pharmacology
Apoptosis
/ drug effects
Cells, Cultured
Etanercept
/ pharmacology
Giant Cells
/ drug effects
Granuloma
/ immunology
Humans
Interleukin-10
/ metabolism
Macrophage Activation
/ drug effects
Macrophages
/ classification
Mycobacterium tuberculosis
/ drug effects
Tuberculosis
/ metabolism
Tumor Necrosis Factor Inhibitors
/ pharmacology
Tumor Necrosis Factor-alpha
/ antagonists & inhibitors
Mycobacterium tuberculosis
etanercept
granuloma
interleukin-10
interleukine-17
multinucleated giant cells
tumor necrosis factor
Journal
Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960
Informations de publication
Date de publication:
2019
2019
Historique:
received:
12
04
2019
accepted:
01
08
2019
entrez:
3
9
2019
pubmed:
3
9
2019
medline:
6
10
2020
Statut:
epublish
Résumé
More than half of tuberculosis cases in the world are due to resuscitation of dormant
Identifiants
pubmed: 31475008
doi: 10.3389/fimmu.2019.01947
pmc: PMC6702871
doi:
Substances chimiques
Anti-Inflammatory Agents
0
Tumor Necrosis Factor Inhibitors
0
Tumor Necrosis Factor-alpha
0
Interleukin-10
130068-27-8
Adalimumab
FYS6T7F842
Etanercept
OP401G7OJC
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1947Références
Infect Immun. 2001 Mar;69(3):1722-8
pubmed: 11179349
Annu Rev Immunol. 2001;19:93-129
pubmed: 11244032
N Engl J Med. 2001 Oct 11;345(15):1098-104
pubmed: 11596589
Am J Pathol. 2002 Feb;160(2):621-30
pubmed: 11839583
Drug Saf. 2002;25(3):173-97
pubmed: 11945114
J Immunol. 2002 May 1;168(9):4620-7
pubmed: 11971010
Ann Rheum Dis. 2002 Nov;61 Suppl 2:ii67-9
pubmed: 12379627
Semin Dial. 2003 Jan-Feb;16(1):38-44
pubmed: 12535299
Expert Opin Drug Saf. 2003 Jul;2(4):347-65
pubmed: 12904092
Lancet Infect Dis. 2003 Sep;3(9):578-90
pubmed: 12954564
J Immunol. 2004 Mar 15;172(6):3695-703
pubmed: 15004173
BioDrugs. 2004;18(2):121-39
pubmed: 15046527
Cell Microbiol. 2004 May;6(5):423-33
pubmed: 15056213
Rheum Dis Clin North Am. 2004 May;30(2):349-64, vii
pubmed: 15172045
J Bacteriol. 2004 Aug;186(15):5017-30
pubmed: 15262939
Clin Immunol. 2004 Nov;113(2):130-6
pubmed: 15451467
Clin Infect Dis. 2004 Oct 15;39(8):1254-5
pubmed: 15486857
Arthritis Rheum. 2005 Jan;52(1):61-72
pubmed: 15641091
Aliment Pharmacol Ther. 2005 Feb 1;21(3):251-8
pubmed: 15691299
Clin Infect Dis. 2005 Aug 1;41 Suppl 3:S199-203
pubmed: 15983900
Inflammopharmacology. 2005;13(4):343-70
pubmed: 16354389
J Biol Chem. 2006 Feb 17;281(7):3866-75
pubmed: 16354661
J Immunol. 2006 Oct 1;177(7):4662-9
pubmed: 16982905
Infect Immun. 2006 Nov;74(11):6108-17
pubmed: 17057088
J Pathol. 2007 Jan;211(1):76-85
pubmed: 17115379
Nat Med. 2008 Jan;14(1):81-7
pubmed: 18157139
Cell. 2009 Jan 9;136(1):37-49
pubmed: 19135887
Immunology. 2009 Jun;127(2):237-48
pubmed: 19489128
Arthritis Rheum. 2009 Jul;60(7):1884-94
pubmed: 19565495
PLoS One. 2009 Jul 22;4(7):e6340
pubmed: 19623255
Nat Immunol. 2009 Sep;10(9):943-8
pubmed: 19692995
J Immunol. 2010 Apr 15;184(8):4414-22
pubmed: 20212094
J Immunol. 2010 Jun 15;184(12):7030-9
pubmed: 20488787
Clin Exp Immunol. 2010 Jul 1;161(1):1-9
pubmed: 20491796
Eur Respir J. 2010 Nov;36(5):1185-206
pubmed: 20530046
Nat Rev Immunol. 2010 Jul;10(7):479-89
pubmed: 20559326
J Immunol Methods. 2010 Aug 31;360(1-2):10-9
pubmed: 20561526
Rheumatology (Oxford). 2010 Nov;49(11):2037-42
pubmed: 20634232
Rheumatology (Oxford). 2010 Dec;49(12):2264-72
pubmed: 20724433
Curr Rheumatol Rep. 2010 Dec;12(6):399-405
pubmed: 20878509
Mucosal Immunol. 2011 May;4(3):252-60
pubmed: 21430655
Front Microbiol. 2011 Jan 26;2:2
pubmed: 21687401
Clin Dev Immunol. 2012;2012:139127
pubmed: 22811737
Pulm Med. 2012;2012:745483
pubmed: 23251798
Mol Immunol. 2013 Jun;54(2):157-63
pubmed: 23287596
PLoS One. 2013;8(1):e53657
pubmed: 23308269
Annu Rev Immunol. 2013;31:475-527
pubmed: 23516984
PLoS One. 2013 Oct 17;8(10):e77680
pubmed: 24147054
Nat Commun. 2014;5:3199
pubmed: 24492460
J Interferon Cytokine Res. 2014 Sep;34(9):716-26
pubmed: 24831609
PLoS Pathog. 2014 May 15;10(5):e1004099
pubmed: 24831696
BMC Infect Dis. 2014 Jul 11;14:387
pubmed: 25015108
Front Cell Infect Microbiol. 2014 Dec 15;4:172
pubmed: 25566510
MBio. 2015 Feb 17;6(1):e02537-14
pubmed: 25691598
Cell. 1989 Mar 10;56(5):731-40
pubmed: 2647299
Emerg Microbes Infect. 2016 Feb 03;5:e10
pubmed: 26839146
Oral Dis. 2016 Apr;22 Suppl 1:53-60
pubmed: 27109273
Int J Biol Sci. 2016 Apr 27;12(6):710-7
pubmed: 27194948
PLoS One. 2016 Jul 21;11(7):e0158528
pubmed: 27441846
Cytokine. 2018 Jan;101:56-63
pubmed: 27567553
Front Cell Infect Microbiol. 2016 Oct 07;6:122
pubmed: 27774438
PLoS Med. 2016 Oct 25;13(10):e1002152
pubmed: 27780211
Cell Mol Immunol. 2017 Dec;14(12):963-975
pubmed: 28890547
J Allergy Clin Immunol. 2018 Aug;142(2):517-529
pubmed: 29248493
Bull World Health Organ. 2018 Mar 1;96(3):173-184F
pubmed: 29531416
J Infect Dis. 2018 Aug 14;218(6):1000-1008
pubmed: 29767733
Front Immunol. 2019 Jan 09;9:3069
pubmed: 30687311
MBio. 2019 Apr 16;10(2):
pubmed: 30992359
Immunity. 1995 Jun;2(6):561-72
pubmed: 7540941
J Immunol. 1993 Apr 1;150(7):3002-10
pubmed: 8454870
J Immunol. 1997 Oct 1;159(7):3565-73
pubmed: 9317156